API | haemophilus influenzae type b conjugate vaccine

haemophilus influenzae type b conjugate vaccine (PedvaxHIB) Report issue

Vaccine Approved ^FDA

AACT MeSH

Active Ingredient History

NOW

Now

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

Drug Pricing (per unit)

United States

$18.7310 - $25.0760

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

acthib | act-hib | dpo 20 vaccine | haemophilus b conjugate vaccine | haemophilus b conjugate vaccine (meningococcal protein conjugate) | haemophilus b conjugate vaccine (tetanus toxoid conjugate) | haemophilus influenzae b oligosaccharide vaccine-diphtheria toxoid conjugate | haemophilus influenzae type b conjugate vaccine | haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate | haemophilus influenzae type b vaccine | haemophilus influenzae type b vaccine, pure polysaccharide | haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate | hib capsular polysaccharide-tetanus vaccine | hib cps-tetanus vaccine | hibest | hib-ps-diphtheria toxoid conjugate vaccine | hib-ps-dt vaccine | hib-tt | hib-vax | omnihib | prohibit | prp-d | prp-t | tetanus toxoid polysaccharide-conjugated vaccine against haemophilus influenzae type b | type b haemophilus influenza conjugate vaccine

Organizations (26)

Research & Development (26)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (24)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (24)

Bacterial Infections (Phase 3)

Communicable Diseases (Phase 2)

Dengue (Phase 1/Phase 2)

Diphtheria (Phase 3)

Dysentery (Phase 2)

Dysentery, Bacillary (Phase 2)

Haemophilus Infections (Phase 4)

Haemophilus influenzae (Phase 4)

Haemophilus influenzae type b (Phase 3)

Healthy Volunteers (Phase 4)

Hepatitis A (Phase 3)

Hepatitis B (Phase 3)

Immunization (Phase 3)

Meningitis (Phase 2)

Meningococcal Infections (Phase 3)

Neisseria meningitidis (Phase 3)

Pertussis Vaccine (Phase 3)

Pneumonia, Pneumococcal (Phase 1/Phase 2)

Poliomyelitis (Phase 3)

Rotavirus Infections (Phase 2)

Tetanus (Phase 3)

Typhoid Fever (Phase 2)

Virus Diseases (Phase 3)

Whooping Cough (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 37
# of Trial Organizations: 26

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue